News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 109–144
- Matches
- 3145
- Sources here
- 17
- Companies here
- 30
Active search
3145 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Seeking Clues to Estee Lauder (EL) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
Analysts on Wall Street project that Estee Lauder (EL) will announce quarterly earnings of $0.32 per share in its forthcoming report, representing an increase of 255.6% year over year. Revenues are projected to reach $3.55 billion, increasing 4.1% from the same quarter last year. …
TJX (TJX) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Wall Street analysts expect TJX (TJX) to post quarterly earnings of $1.18 per share in its upcoming report, which indicates a year-over-year increase of 7.3%. Revenues are expected to be $15.14 billion, up 5.1% from the year-ago quarter. The current level reflects an upward …
Sharemaestro market context Price below Trend Line 52 weeks -1.7%Insights Into Lowe's (LOW) Q2: Wall Street Projections for Key Metrics
Analysts on Wall Street project that Lowe's (LOW) will announce quarterly earnings of $4.22 per share in its forthcoming report, representing a decline of 2.5% year over year. Revenues are projected to reach $26.18 billion, increasing 9.3% from the same quarter last year. Over …
Sharemaestro market context Price below Trend Line 52 weeks -24.0% · Next-week setup negative 41.8%The Estée Lauder Companies and University of Leeds Partner to Advance the Future of Complexion Shade Matching
Foundation shades are blended as part of color science research.Dr. Kaida Xiao, Professor of Color and Imaging Science at the University of Leeds, holds a color chart. New research aims to tackle one of beauty's most persistent challenges: accurately matching shade complexion-enhancing products to …
Sharemaestro market context Price below Trend Line 52 weeks -9.7%Travelers Companies stock trades just below record highs as Dow component benefits from solid earnin
Travelers Companies stock is trading near its record high, driven by solid insurance earnings and cautious valuation metrics. Despite being just below its peak, the company's P/E and price-to-book ratios suggest a conservative valuation compared to other financial peers. Analyst ratings are generally "Hold," …
KinderCare Learning Companies (NYSE:KLC) Downgraded by JPMorgan Chase & Co. to Underweight
JPMorgan Chase & Co. has downgraded KinderCare Learning Companies (NYSE:KLC) from "neutral" to "underweight," reflecting a mixed analyst outlook for the company. KLC shares opened at $4.77, up 2.9%, despite recently missing quarterly earnings expectations and reporting negative net margins. The stock shows high …
Kindercare expects $2.66B-$2.7B revenue and $0.05-$0.15 adjusted EPS as it targets 80-85 center closures in 2026
Earnings Call Insights: KinderCare Learning Companies, Inc. (KLC) Q2 2026 MANAGEMENT VIEW * “We delivered results largely in line with expectations, along with a few bright spots that reinforce the progress we are making,” said (Chairman & CEO John Wyatt), while outlining priorities of …
Loma Negra (LOMA) Q2 2026 Earnings Call Transcript
Loma Negra (LOMA) reported a mixed Q2 2026, with consolidated net revenue increasing 2.1% year-over-year to Ps. 238.1 billion due to positive pricing, despite a 1.4% decrease in cement sales volume attributed to heavy April rains. Consolidated Adjusted EBITDA declined 2.5% to Ps. 48.2 …
Wealth Enhancement Advisory Services LLC Buys 198,368 Shares of The TJX Companies, Inc. $TJX
Wealth Enhancement Advisory Services LLC increased its stake in The TJX Companies, Inc. by 20% in Q2, purchasing 198,368 additional shares to bring its total holdings to 1.19 million shares valued at approximately $171.8 million. This acquisition comes as TJX reported stronger-than-expected earnings and …
The TJX Companies, Inc. $TJX Shares Acquired by Hendley & Co. Inc.
Hendley & Co. Inc. significantly increased its stake in The TJX Companies, Inc. (NYSE:TJX) by 566.4% in Q2 2026, acquiring 19,201 additional shares, bringing its total to 22,591 shares valued at $3.42 million. Institutional investors collectively own 91.09% of TJX, while analysts maintain a …
The Travelers Companies, Inc. $TRV Shares Purchased by Sequoia Financial Advisors LLC
Sequoia Financial Advisors LLC increased its stake in The Travelers Companies, Inc. (NYSE:TRV) by 12.8% in the second quarter, now holding 33,397 shares valued at $11 million. This comes as institutional investors own 82.45% of the insurer's stock. Travelers reported strong quarterly earnings, beating …
QRG Capital Management Inc. Increases Position in The TJX Companies, Inc. $TJX
QRG Capital Management Inc. has increased its stake in The TJX Companies, Inc. by 6.8% in the second quarter, bringing its total holdings to 323,830 shares valued at approximately $49.1 million. This comes as TJX recently surpassed quarterly earnings and revenue expectations, driven by …
KinderCare trims 2026 revenue outlook, sees EPS below consensus
[Letters Q2 on a wooden desk alongside a laptop, a book, and a desk calendar.] mohd izzuan KinderCare Learning Companies (KLC [https://seekingalpha.com/symbol/KLC]) shares fell 19% in premarket trading Friday after the childcare provider reported Q2 adjusted earnings that missed estimates and lowered its FY …
The TJX Companies, Inc. $TJX Stake Increased by Brookstone Capital Management
Brookstone Capital Management significantly increased its stake in The TJX Companies (NYSE:TJX) by 279.2% during the second quarter, now holding 49,035 shares valued at $7.43 million. This comes as institutional investors collectively own 91.09% of the company. TJX reported strong quarterly earnings, beating estimates …
The Top 5 Analyst Questions From ANI Pharmaceuticals’s Q2 Earnings Call
ANI Pharmaceuticals reported strong Q2 year-on-year growth in its rare disease and generics businesses, exceeding analyst estimates for revenue, EPS, and EBITDA, though the market reacted negatively. CEO Nikhil Lalwani highlighted significant momentum in demand for Cortrophin Gel. Analysts focused on the gout expansion, …